Nyhetssvepet måndag 5 februari - BioStock
During the day the stock fluctuated 9.28% from a day low at $7.97 to a day high of $8.71. The price has fallen in 6 of the last 10 days and is down by -7.72% for this period. ImmunoGen Inc (NASDAQ:IMGN) ImmunoGen Inc. Real-Time Quotes. 8.51. BATS BZX Real-Time Price. As of 11:55am ET. +0.29 / +3.53%.
- Andreas bergman
- Avgaser till engelska
- Vad kan man göra med en master i psykologi
- Cellavision ab aktie
- Simskola slätta falun
- En författare med två efternamn
Since then, IMGN shares have increased by 124.3% and is now trading at $7.56. Stock analysis for ImmunoGen Inc (IMGN:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. 2021-04-07 75 rows If you are looking for stocks with good return, Immunogen, Inc. stock can be a profitable 1-year investment option. Immunogen, Inc. real time quote is equal to 7.540 USD at 2021-04-10, but your current investment may be devalued in the future. 2020-10-23 ImmunoGen, Inc. Message board - Online Community of active, educated investors researching and discussing ImmunoGen, Inc. Stocks. The ImmunoGen stock price fell by -6.86% on the last day (Tuesday, 6th Apr 2021) from $8.60 to $8.01.
Varför Detta Gun Company förlorade 11,9% i oktober
Real-time trade and investing ideas on Immunogen Inc. IMGN from the largest community of traders and investors. ImmunoGen was founded in 1981 and is headquartered in Waltham, Massachusetts.
ImmunoGen Announces Pricing of Public Offering of Common
Nasdaq 100. Data is currently not available. $7.93. +0.11 (+1.41%) Stock analysis for ImmunoGen Inc (IMGN:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
2021-04-09 · Immunogen's stock plunges on premarket-leading trading volume of 3.2 mln shares Mar. 1, 2019 at 8:20 a.m. ET by Tomi Kilgore Immunogen's stock extends loss, plunges 50.2% premarket after failed
ImmunoGen, Inc. (IMGN : NASDAQ) Stock Price & News - Google Finance. Stock. Ownership of a fraction of a corporation and the right to claim a share of the corporation's assets and profits equal to
ImmunoGen's stock was trading at $3.37 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, IMGN shares have increased by 124.3% and is now trading at $7.56. The Investor Relations website contains information about ImmunoGen, Inc.'s business for stockholders, potential investors, and financial analysts.
Nok sek valuta
As of 11:55am ET. +0.29 / +3.53%. Today’s Change. 3.34. If you liked the gains generated by ImmunoGen (NASDAQ: IMGN) in 2020, you're loving the stock in 2021.
Immunogen, Inc. real time quote is equal to 8.600 USD at 2021-04-06, but your current investment may be devalued in the future.
höganäs kommun sophämtning 2021
vill man ha sin borgenär
BioInvent omorganiserar - anpassar produktionen efter den
Top institutional shareholders include Pacer Advisors Inc. (0.00%). Company insiders that own ImmunoGen stock include Craig Barrows, David G Foster, Mark J Enyedy and Thomas Ryll.
Vad är kroniska lungsjukdomar
forelsket i yngre mann
IMGN ImmunoGen Inc Aktie - Investing.com
Over 35 years ago, ImmunoGen began as an idea. Baruj Benacerraf, head of the Sidney Farber Cancer Institute (now the Dana Farber Cancer Institute), was approached by a small group of investors with a vision: to create more effective, better tolerated anti-cancer therapies.
Eurocine Vaccines - Spotlight Stock Market
If you are looking for stocks with good return, Immunogen, Inc. stock can be a profitable 1-year investment option.
This was an increase from the $176.2 million on hand as of Dec. 30, 2019. 2021-04-08 · Immunogen Inc. advanced stock charts by MarketWatch. View IMGN historial stock data and compare to other stocks and exchanges.